Genetic fine-mapping from summary data using a nonlocal prior improves the detection of multiple causal variants
Ville Karhunen1,2, Ilkka Launonen1, Marjo-Riitta Järvelin2,3,4
1Research Unit of Mathematical Sciences, University of Oulu, Oulu, P.O.Box 8000, FI-90014, Finland.
Bioinformatics (Oxford, England)
|June 22, 2023
Summary
FiniMOM is a new Bayesian fine-mapping method that improves the detection of causal genetic variants from genome-wide association studies (GWAS). This method enhances credible set coverage and power, particularly when multiple causal variants are present within a locus.
Area of Science:
- Genetics
- Statistical Genetics
- Bioinformatics
Background:
- Genome-wide association studies (GWAS) identify genomic loci linked to complex traits.
- Genetic fine-mapping refines these loci to pinpoint independent causal variants, accounting for linkage disequilibrium.
Purpose of the Study:
- To introduce FiniMOM, a novel Bayesian fine-mapping method for summarized genetic association data.
- To improve the accuracy and power of identifying causal variants in complex genetic loci.
Main Methods:
- FiniMOM utilizes a nonlocal inverse-moment prior for causal effects, suitable for finite samples.
- A beta-binomial prior models the number of causal variants, allowing control for linkage disequilibrium reference misspecification.
- The method was evaluated using simulation studies mimicking GWAS on circulating protein levels.
Main Results:
- FiniMOM demonstrated improved credible set coverage compared to the state-of-the-art SuSiE method.
- The proposed method showed enhanced power in detecting causal variants, especially in scenarios with multiple causal variants per locus.
- Simulation results confirmed FiniMOM's effectiveness in fine-mapping genetic loci.
Conclusions:
- FiniMOM offers a robust Bayesian approach for genetic fine-mapping using summarized association data.
- The method provides superior performance over existing tools, particularly for complex loci with multiple causal variants.
- FiniMOM is a valuable tool for researchers aiming to precisely identify causal variants from GWAS.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Comparing Copy Number Variations and SNPs
17.8K
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
17.8K
Single Nucleotide Polymorphisms-SNPs
15.3K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.3K
Genetic Screens
5.0K
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which...
5.0K


